Back to top

Surging Earnings Estimates Signal Good News for Delek US Holdings (DK)
September 22, 2017

Read MoreHide Full Article

Delek US Holdings, Inc. (DK - Free Report) is a diversified energy company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on DK’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Delek US Holdings could be a solid choice for investors.

Current Quarter Estimates for DK

In the past 30 days, four estimates have gone higher for Delek US Holdings while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from 28 cents a share 30 days ago, to 52 cents today, a move of 85.7%.

Current Year Estimates for DK

Meanwhile, Delek US Holdings’s current year figures are also looking quite promising, with four estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from a loss of 15 cents per share 30 days ago to earnings of 26 cents per share today, a significant move.

Bottom Line

The stock has also started to move higher lately, adding 19.9% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So, investors may want to consider this Zacks Rank #3 (Hold) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.

See these buy recommendations now >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Delek US Holdings, Inc. (DK) - free report >>


More from Zacks Tale of the Tape

You May Like